Open access
Aug 2026
Plasma metabolomic signatures enable the diagnosis and prognosis of chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is a progressive heterogeneous lung disease driving global illness and death, yet reliable biomarkers for its early diagnosis, molecular subtyping and prognosis are lacking. Here, we conduct targeted plasma metabolomic profiling in two independent, deeply phenotyped cohorts...
Chen Li, Jie Yao, Fan Wu et al.
· Nature Communications · 0 citations